SCHEMBL8736285

SCHEMBL8736285

CCCCCCOc1ccc([S+]2CCCC2)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.47
CNR2 P34972 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 1/20 0.47
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
CYP2C9 P11712 1/20 0.45
SLC2A1 P11166 1/20 0.41
NR1I2 O75469 1/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2A P08913 1/20 0.40
MAPT P10636 1/20 0.40
OPRK1 P41145 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A3 Q01959 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2742104 1.00 CNR1 (0.47) CNR1CNR2MEN1KMT2AHTT
SCHEMBL8737935 1.00 CNR1 (0.47) CNR1CNR2MEN1KMT2AHTT
SCHEMBL29429149 0.94 CNR1 (0.45) CNR1CNR2MEN1KMT2AHTT
SCHEMBL106524 0.94 CNR1 (0.45) CNR1CNR2MEN1KMT2AHTT
Bromide SCHEMBL2194103 0.93 CNR1 (0.44) CNR1CNR2MEN1KMT2AHTT
Hydrochloric Acid SCHEMBL31108778 0.93 CNR1 (0.44) CNR1CNR2MEN1KMT2AHTT
SCHEMBL3454520 0.90 CNR2 (0.42) CNR1CNR2MEN1KMT2AHTT
SCHEMBL31040506 0.90 CNR1 (0.44) CNR1CNR2MEN1KMT2AHTT
SCHEMBL702260 0.90 CNR1 (0.44) CNR1CNR2MEN1KMT2AHTT
SCHEMBL5866191 0.86 SLC2A1 (0.43) CNR1CNR2MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME ACTR8, RAD51, ACTR2 CNR1 3105/4885CNR2 3504/4885MEN1 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.